Skip to main content
OpenTrials

Clinical trial condition

Stomach Neoplasms

Explore clinical trials studying Stomach Neoplasms. Study availability and eligibility vary by location and protocol.

1,999 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Stomach Neoplasms trial results

Completed

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

NCT04825834

Conditions
Bladder Cancer, Colonic Diseases, Colorectal Cancer, +48 more
Locations
  • Central Alabama Research Homewood, Alabama, United States
  • Phoenix Medical Group Peoria, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Pulmonary Associates of Burlingame Burlingame, California, United States
View all 57 locations
View Trial Details
Completed

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

NCT02872116

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Local Institution - 0005 Los Angeles, California, United States
  • Local Institution - 0001 San Francisco, California, United States
  • Local Institution - 0066 Aurora, Colorado, United States
  • Local Institution - 0151 Denver, Colorado, United States
View all 179 locations
View Trial Details
Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

NCT02903914

Conditions
Adenocarcinoma, Adenoma, Bladder Cancer, +49 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Honor Health/Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Georgetown Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

NCT02205047

Conditions
Digestive System Diseases, Digestive System Neoplasms, Epidermal Growth Factor Receptor (EGFR) Protein Overexpression, +8 more
Locations
  • University Hospital Gent Ghent, Flanders, Belgium
  • North Estonia Medical Centre Tallinn, Estonia
  • CHRU de Besancon - Hopital Jean Minjoz Besançon, France
  • CHRU de Lille - Hopital Huriez Lille, France
View all 48 locations
View Trial Details
Completed

Predicting the Efficacy in Advanced Gastric Cancer.

NCT06490055

Conditions
Chemotherapy Effect, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Department of Molecular Diagnostics and Experimental Therapeutics Monrovia, California, United States
  • Kawasaki Medical University Kurashiki, Okayama-ken, Japan
View Trial Details
Completed

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

NCT02611024

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Tumors, +53 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Massachusetts General Hospital - Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details

Related conditions